---
$id: https://graph.org.ai/products/commodity/51263401
$type: Product
source: UNSPSC
code: "51263401"
title: "Yohimbine"
class: "51263400"
classTitle: "Adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Yohimbine

**UNSPSC Code**: 51263401
**Class**: [Adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides](Adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C21H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Y49VWD90Q, chemically known as 20.alpha.-yohimban-16.beta.-carboxylic acid, 17.alpha.-hydroxy-, methyl ester, monohydrochloride but generally known as yohimbine, which bears US NIH Compound Identifier 2866. European Medicines Agency schedules Yohimbine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15744MIG. World Health Organization schedules yohimbine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule yohimbine under HS 29399990 and SITC 54149. As of Q4 2014, YOHIMBINE remains the US FDA Preferred Term for this commodity. Yohimbine bears US NLM identifiers UMLS ID C0724441 and NCI Concept Code C77304. SMILES: OC1C(C2C(CN3C(C2)C2[NH]C4C(C2CC3)CCCC4)CC1)C(=O)OC.

